Ultra-high single-dose radiation therapy for intermediate-risk prostate cancer is safe and associated with low toxicity. It offers tumor control and quality-of-life outcomes comparable to those of curative hypofractionated stereotactic body radiotherapy.
Назад к списку
Ultra-high single-dose radiation therapy for intermediate-risk prostate cancer is safe and associated with low toxicity. It offers tumor control and quality-of-life outcomes comparable to those of curative hypofractionated stereotactic body radiotherapy.